• Contact Us
    • Contact Us
    • Adverse Event
  • Newsroom
    • Newsroom
    • Press Releases
    • Media Library
    • Corporate Press Kit
    • Product & Pipeline Media Resources
  • South Africa
    • Global
    • ArgentinaAustraliaAustriaBrazil
      CanadaENFR
      ChinaDenmarkFinland
      FranceGermanyItalyJapanMalaysiaMENANetherlandsNorway
      SingaporeSouth KoreaSpainSweden
      SwitzerlandDEFRIT
      UKUnited States
  • Investors
    • NASDAQ
    • HKEX
    • SSE
  • Medical Information
BeOne Logo
  • About
    • About Us
    • Our Brand
    • Our Offices
  • Science
    • Research and Development
      • Research & Development Overview
      • Disease Focus Areas: Haematology
      • Disease Focus Areas: Solid Tumours
      • Pioneering Protein Degradation with CDACs
      • Antibody Drug Conjugates
    • Pipeline
    • Clinical Trials
      • Find a Trial
  • Patients
    • Our Commitment to Patients
    • Global Patient Safety
  • Responsibility
    • Operating Responsibly
      • Operating Responsibly Overview
      • Policies & Positions
      • Suppliers
      • Global Transparency
  • Careers
    • See Open Positions
  • Contact Us
    • Contact Us
    • Adverse Event
  • Newsroom
    • Newsroom
    • Press Releases
    • Media Library
    • Corporate Press Kit
    • Product & Pipeline Media Resources
  • South Africa
    • Global
    • ArgentinaAustraliaAustriaBrazil
      CanadaENFR
      ChinaDenmarkFinland
      FranceGermanyItalyJapanMalaysiaMENANetherlandsNorway
      SingaporeSouth KoreaSpainSweden
      SwitzerlandDEFRIT
      UKUnited States
  • Investors
    • NASDAQ
    • HKEX
    • SSE
  • Medical Information
BeOne Logo

EXTERNAL LINKS

  • NASDAQ Investors
  • HKEX Investors
  • SSE Investors
  • Medical Information
  • Terms of Use
  • Privacy Policy

© BeOne Medicines I GmbH, 2025 All Rights Reserved.